Pioneering tissue-specific gene therapies to rejuvenate tissues, improve organ function and, ultimately, delay aging.

At YouthBio, our mission is to harness the power of cellular reprogramming to restore a more youthful gene expression profile in targeted cells, leading to positive therapeutic effects in corresponding organs. Our ultimate goal is achieving systemic rejuvenation by targeting multiple key organ systems via tailored therapies. To get there, we are first starting with single-organ therapies aimed at existing diseases.

Discover the incredible potential of partial reprogramming to revolutionize the way we combat and prevent age-related diseases, and ultimately delay or possibly even reverse aging.

YouthBio Therapeutics Executive Team

• Yuri Deigin - Co-founder and Director
  
• Viet Ly - Co-founder and CFO
• João Pedro de Magalhães - Chief Scientific Officer
• Alejandro Ocampo - Lead Research Collaborator
• Stephanie Chang - CFO